Atlas Trials

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

Clinical trial NCT07062848 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07062848
Sponsor
Yale University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Transthyretin (TTR) Amyloid Cardiomyopathy
Start date
2025-01-24
Primary completion
2027-01-01
Enrollment
1500000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.